Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Contact Lenses | 7 | 2024 | 138 | 1.390 |
Why?
|
Dexamethasone | 2 | 2021 | 1965 | 0.490 |
Why?
|
Hydrogels | 3 | 2024 | 745 | 0.480 |
Why?
|
Tears | 3 | 2024 | 252 | 0.450 |
Why?
|
Drug Delivery Systems | 4 | 2024 | 2238 | 0.390 |
Why?
|
Scapula | 2 | 2009 | 176 | 0.350 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2012 | 462 | 0.340 |
Why?
|
Arthroscopy | 3 | 2009 | 971 | 0.290 |
Why?
|
Rabbits | 7 | 2024 | 4786 | 0.280 |
Why?
|
Ligaments, Articular | 1 | 2009 | 304 | 0.280 |
Why?
|
Polyethylene Glycols | 1 | 2012 | 1195 | 0.260 |
Why?
|
Corneal Diseases | 2 | 2022 | 539 | 0.260 |
Why?
|
Prostaglandins F, Synthetic | 2 | 2016 | 32 | 0.250 |
Why?
|
Ilizarov Technique | 1 | 2004 | 13 | 0.240 |
Why?
|
Knee Injuries | 1 | 2009 | 495 | 0.230 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2005 | 119 | 0.230 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2021 | 1543 | 0.220 |
Why?
|
Fractures, Open | 1 | 2004 | 107 | 0.220 |
Why?
|
Nerve Growth Factor | 1 | 2024 | 157 | 0.210 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2005 | 259 | 0.210 |
Why?
|
Chitosan | 1 | 2024 | 141 | 0.210 |
Why?
|
Military Personnel | 2 | 2009 | 1264 | 0.200 |
Why?
|
Debridement | 1 | 2004 | 494 | 0.190 |
Why?
|
Epithelium, Corneal | 1 | 2024 | 254 | 0.190 |
Why?
|
Photorefractive Keratectomy | 1 | 2021 | 38 | 0.190 |
Why?
|
Tibial Fractures | 1 | 2004 | 276 | 0.190 |
Why?
|
Spinal Stenosis | 1 | 2003 | 261 | 0.170 |
Why?
|
Azepines | 1 | 2021 | 329 | 0.170 |
Why?
|
Fluoroquinolones | 1 | 2021 | 309 | 0.170 |
Why?
|
Posterior Eye Segment | 1 | 2019 | 18 | 0.170 |
Why?
|
Orthopedic Procedures | 1 | 2009 | 1280 | 0.160 |
Why?
|
Cicatrix | 2 | 2022 | 799 | 0.160 |
Why?
|
Spinal Neoplasms | 1 | 2005 | 715 | 0.160 |
Why?
|
Keratitis | 1 | 2021 | 241 | 0.150 |
Why?
|
Delayed-Action Preparations | 2 | 2019 | 969 | 0.150 |
Why?
|
Cornea | 3 | 2022 | 1332 | 0.150 |
Why?
|
Macular Edema | 1 | 2022 | 387 | 0.150 |
Why?
|
Administration, Topical | 1 | 2019 | 707 | 0.140 |
Why?
|
Shoulder Pain | 2 | 2009 | 152 | 0.140 |
Why?
|
Drug Carriers | 1 | 2021 | 712 | 0.140 |
Why?
|
Uveitis | 1 | 2020 | 398 | 0.130 |
Why?
|
Glaucoma | 2 | 2016 | 1192 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 1 | 2021 | 1197 | 0.120 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7467 | 0.120 |
Why?
|
Coated Materials, Biocompatible | 1 | 2016 | 311 | 0.120 |
Why?
|
RNA | 1 | 2024 | 2728 | 0.110 |
Why?
|
Fluorescein Angiography | 1 | 2019 | 1086 | 0.110 |
Why?
|
Intraocular Pressure | 2 | 2016 | 1304 | 0.110 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 1299 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2021 | 2170 | 0.100 |
Why?
|
Proteomics | 1 | 2024 | 3901 | 0.090 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 506 | 0.090 |
Why?
|
Cell Proliferation | 2 | 2024 | 10490 | 0.080 |
Why?
|
Molecular Weight | 1 | 2012 | 2173 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10784 | 0.080 |
Why?
|
Cytokines | 1 | 2024 | 7440 | 0.080 |
Why?
|
Retina | 1 | 2019 | 2663 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3520 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2005 | 9425 | 0.070 |
Why?
|
Acromioclavicular Joint | 1 | 2007 | 78 | 0.060 |
Why?
|
Tissue Scaffolds | 1 | 2012 | 948 | 0.060 |
Why?
|
Posture | 1 | 2009 | 956 | 0.060 |
Why?
|
Clavicle | 1 | 2007 | 224 | 0.060 |
Why?
|
Mucin 5AC | 1 | 2024 | 96 | 0.060 |
Why?
|
Cell Culture Techniques | 1 | 2012 | 1669 | 0.060 |
Why?
|
Methacrylates | 1 | 2024 | 110 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18390 | 0.060 |
Why?
|
Corneal Stroma | 1 | 2024 | 170 | 0.050 |
Why?
|
Animals | 9 | 2024 | 169424 | 0.050 |
Why?
|
Fractures, Ununited | 1 | 2004 | 176 | 0.050 |
Why?
|
Myofibroblasts | 1 | 2024 | 232 | 0.050 |
Why?
|
Limbus Corneae | 1 | 2024 | 145 | 0.050 |
Why?
|
Military Medicine | 1 | 2004 | 185 | 0.050 |
Why?
|
Cell Survival | 1 | 2012 | 5800 | 0.050 |
Why?
|
Acetabulum | 1 | 2006 | 543 | 0.050 |
Why?
|
Tissue Engineering | 1 | 2012 | 1890 | 0.050 |
Why?
|
Aqueous Humor | 1 | 2021 | 153 | 0.050 |
Why?
|
Lasers, Excimer | 1 | 2021 | 69 | 0.050 |
Why?
|
Cross-Linking Reagents | 1 | 2024 | 692 | 0.050 |
Why?
|
Eye Proteins | 1 | 2024 | 633 | 0.050 |
Why?
|
Limit of Detection | 1 | 2021 | 277 | 0.040 |
Why?
|
Humans | 16 | 2024 | 768369 | 0.040 |
Why?
|
Ophthalmic Solutions | 1 | 2021 | 315 | 0.040 |
Why?
|
Hip Joint | 1 | 2006 | 1018 | 0.040 |
Why?
|
Physical Therapy Modalities | 1 | 2003 | 533 | 0.040 |
Why?
|
Recovery of Function | 1 | 2009 | 2994 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2024 | 1100 | 0.040 |
Why?
|
Fluorescence | 1 | 2021 | 760 | 0.040 |
Why?
|
Stromal Cells | 1 | 2024 | 1335 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15879 | 0.040 |
Why?
|
Bibliometrics | 1 | 2022 | 354 | 0.040 |
Why?
|
Spine | 1 | 2005 | 1142 | 0.040 |
Why?
|
Chronic Disease | 2 | 2009 | 9379 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2003 | 941 | 0.030 |
Why?
|
Tonometry, Ocular | 1 | 2016 | 238 | 0.030 |
Why?
|
Anterior Eye Segment | 1 | 2016 | 144 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 17149 | 0.030 |
Why?
|
Steroids | 1 | 2020 | 937 | 0.030 |
Why?
|
Fibrosis | 1 | 2022 | 2076 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2005 | 6856 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2024 | 6527 | 0.030 |
Why?
|
Fractures, Bone | 1 | 2006 | 2063 | 0.030 |
Why?
|
Proteome | 1 | 2024 | 1881 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2016 | 903 | 0.030 |
Why?
|
Adult | 6 | 2009 | 223528 | 0.030 |
Why?
|
Radiography | 1 | 2005 | 6995 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4180 | 0.030 |
Why?
|
Drug Stability | 1 | 2013 | 291 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2009 | 65408 | 0.030 |
Why?
|
Cell Movement | 1 | 2024 | 5223 | 0.020 |
Why?
|
Male | 6 | 2024 | 364761 | 0.020 |
Why?
|
Female | 8 | 2021 | 396926 | 0.020 |
Why?
|
Inflammation | 2 | 2022 | 10863 | 0.020 |
Why?
|
Porosity | 1 | 2012 | 352 | 0.020 |
Why?
|
Wound Healing | 1 | 2022 | 2819 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 669 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2024 | 19035 | 0.020 |
Why?
|
Materials Testing | 1 | 2012 | 871 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3530 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 2028 | 0.020 |
Why?
|
Rib Fractures | 1 | 2006 | 129 | 0.020 |
Why?
|
Multiple Trauma | 1 | 2006 | 370 | 0.010 |
Why?
|
Pregnancy | 1 | 2005 | 30179 | 0.010 |
Why?
|
Tomography, Optical Coherence | 1 | 2016 | 2958 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2006 | 952 | 0.010 |
Why?
|
Young Adult | 1 | 2009 | 60038 | 0.010 |
Why?
|
Accidents, Traffic | 1 | 2006 | 821 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26348 | 0.010 |
Why?
|
Middle Aged | 2 | 2009 | 223406 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 36840 | 0.010 |
Why?
|
Pain Measurement | 1 | 2007 | 3577 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39429 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2007 | 3484 | 0.010 |
Why?
|
United States | 1 | 2022 | 73120 | 0.010 |
Why?
|
Mice | 1 | 2012 | 82051 | 0.000 |
Why?
|
Aged | 1 | 2006 | 171514 | 0.000 |
Why?
|
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_